SlideShare a Scribd company logo
The NHS Funding Challenge
‘productivity isn’t everything, but in the long
run it is almost everything’ - Paul Krugman
Anita Charlesworth
Chief Economist
5th February 2015
Public spending on health in the UK, in real terms
and as a percentage of GDP (2014/15 prices)
2
Average yearly change in UK health spending over
different parliaments (2014/15 prices)
3
The annual change in English NHS spending since
2009/10
4
Public and private health care spending in the UK
(£bn) – 1997-2012 (2014/15 prices)
5
Total health spending as a percentage of GDP for
the EU-15 countries, 2000 and 2012
6
Average annual percentage change in health
spending per head in real terms, 2008-2012
7
Meeting the Challenge – the NHS approach
8
Reducing input costs
National public sector pay policy
Reducing administrative costs
Reducing prices of pharmaceuticals
Improving technical efficiency
Real terms reduction in the unit prices paid for hospital care
More competitive tender and choice based competition for NHS
funded care
Improving allocative efficiency
Shifting care from hospital to community settings
Better integration of care
Demand management
Where is the NHS now?
9
Overall NHS in balance last year (just £247m under-spend for DH as a
whole in 2013/14).
Quality broadly being maintained but cracks beginning to appear.
But significant pressure points.
Specialised services budget over-spending.
Access targets getting more difficult to sustain.
66 NHS providers in deficit in 2013/14 – almost 141 at Q2 2014/15.
Most have a small deficit but up to 20 with large, persistent deficits.
40% of acute providers in deficit in 2013/14, 80% at Q2 2014/15.
Surpluses falling, EBITDA and CIPs lower and a reliance on one-off
savings building cumulative underlying deficits.
2014-15 very difficult for the service to recover and not overspend.
-2%
-1%
0%
1%
2%
3%
4%
5%
2005/06 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12 Annual
average
growth
Productivity Growth Year on Year
Annual change in English NHS productivity
10
Source: Centre for Health Economics, Research Paper 94
Annual change in English NHS funding, 2010/11
to 2015/16, following the 2014 Autumn Statement
NHS administration costs from 2009/10 to
2015/16, real terms
12
Percentage change from previous year in funding
for a range of services
13
Purchase of health care from non-NHS providers
from 2006/07 to 2013/14 (2013/14 prices)
14
Annual change in the number of nurses from
2011/12 to 2013/14
15
Average NHS staff earnings from 2009/10 to
2013/14
16
Net reported year-to-date surplus/deficit by
sector, 2014/15 Q2
17
Quality, Innovation and Productivity (QIPP)
savings, 2011/12 to 2014/15
18
Public spending on health in the UK, as a percentage
of total public spending
19
NHS England estimates of funding pressures facing
the NHS in England by the end of the decade
20
Health care outputs, inputs and productivity estimates
for the UK, 1995-2010 (index numbers 1995=100)
21
Projected funding gap for English NHS in
2030/31 under three assumptions for productivity
22
Source: The Health Foundation (2015)
Funding pressures on English NHS in 2030/31
(2014/15 prices)
23
OECD projections for average public spending on health for
EU15 countries, as a percentage of GDP between 2006 and 2010,
with projected spend in 2060 under both cost-containment and
cost-pressure assumptions
24
Conclusions
25
The NHS has been protected from the full impact of the government’s austerity
drive to tackle the fiscal deficit. Despite this, the service is showing growing signs of
financial distress and in December 2014, the Government found itself having to
inject significant additional resources into the service for both 2014/15 and 2015/16.
After the election, all political parties are committed to reducing the fiscal deficit,
which will involve cuts to public spending. Health care now accounts for almost £1
in every £5 of government spending – just sustaining, let alone improving, the
quality of care while delivering fiscal balance will be one of the major challenges
facing any incoming government.
NHS England has set out an ambitious programme of reform for the NHS in the
recent Five year forward view. This is designed to improve the system’s productivity
and modernise care to ensure that it meets the needs of an ageing population with
growing rates of chronic disease.
There is no doubt that change on this scale is required. The key question is can it
be delivered quickly enough to unlock the required productivity savings. Under NHS
England’s most demanding productivity assumption, they recognise that the NHS
will still need an addition £8bn extra over and above inflation by 2020/21.
Conclusions
26
An incoming government needs to:
 Provide meaningful support for rapid progress on the new models of care set out in the Five year
forward view. A key part of this support will be to establish and resource a ‘transformation’ fund to
provide the financial assistance necessary to underpin change.
 Commit to the additional annual funding for the NHS specified by NHS England, which rises to £8
billion of additional funding over and above inflation in 2020/21, while recognising that this is a low
estimate and if pay pressures turn out to be higher than anticipated, the NHS will need further
resources to maintain quality and access.
The funding challenge facing the NHS doesn’t disappear beyond the current parliament
even if the NHS succeeds in implementing the vision set out in the Five year forward
view.
 Even with unprecedented productivity improvements of over 2 per cent a year the funding
pressures facing the NHS would rise to £48 billion more than inflation by 2030/31.
 Our central estimates using the recent trend of 1.5% productivity improvements see funding
pressures increasing to £65 billion more than inflation by 2030/31.
If successive governments are to meet these pressures NHS funding needs to grow
slightly faster than GDP. Over recent decades other public services have reduced as a
share of GDP, creating headroom for the health service without the need to increase
taxes. It is difficult to see how this can continue indefinitely and there needs to be
societal agreement about how to sustain the health service in the longer term.
The four steps used to project funding pressures
Regression results
28
Model: AE OP
Age split: 0 01-19 20-49 50-84 85+ 0 01-19 20-49 50-84 85+
Intercept -0.6403 -0.6555 -0.2141 -1.764 -1.2116 -0.3276 -0.459 -0.5608 -1.0967 0.9262
Female -0.1843 -0.1687 -0.1061 0 0 -0.1762 0.0224 0.7969 0.0464 -0.2718
Agecat 0 -0.0607 -0.112 0 0 0 0.022 0.0104 0.0991 0
Diedinyear 0 0.2948 0.7057 0.2715 -0.1321 0.1983 0.7421 0.1455 -0.483 -1.0498
Gor_B 0.2138 -0.0508 0.0542 0.0961 0.1369 0.1089 -0.1299 0.0356 0.1153 0.1269
Gor_D -0.0313 -0.1905 -0.1857 -0.0974 -0.0063 -0.0888 -0.1455 -0.1782 0.0039 0.0653
Gor_E -0.1832 -0.295 -0.2692 -0.1582 -0.1264 0.0306 -0.2367 -0.183 -0.0559 -0.047
Gor_F 0.0546 -0.1564 -0.0331 0.0471 0.0689 0.2798 -0.0566 0.088 0.1964 0.1982
Gor_G -0.2545 -0.4819 -0.4141 -0.253 -0.1051 0.1938 -0.2372 -0.1661 -0.0715 -0.0564
Gor_H 0.3691 0.0308 0.0054 0.3736 0.3134 0.1484 -0.0777 0.0759 0.3236 0.4349
Gor_J -0.3327 -0.459 -0.3825 -0.1739 -0.0619 0.2504 -0.2298 -0.2413 -0.1213 -0.0662
Gor_K -0.3657 -0.3064 -0.2747 -0.151 -0.1981 0.057 -0.0668 -0.1598 -0.0016 0.0583
J_Diab 2.0715 1.3932 1.6104 1.3196 1.0511 0 2.2116 1.8219 1.2987 0.7136
J_Copd_Asthma 1.0337 1.5459 1.5297 1.6106 1.2884 1.19 1.5803 1.436 1.1796 0.6371
J_Arthritis 1.4887 0.9166 1.2038 1.2692 1.2351 0 2.7632 1.9332 1.4955 0.6891
J_Epilepsy 1.7454 1.719 2.0015 2.0342 1.465 2.0379 2.3319 1.511 1.1205 0.6032
J_Mh 0 1.9026 1.9337 1.9558 0.7855 0 0.7935 0.3779 0.2489 0
J_Stroke 0.8288 1.3728 1.8504 1.8854 1.4531 2.1757 2.5433 1.5959 0.8992 0.3001
J_Renal 0 1.3425 1.5858 1.5909 1.3334 1.8159 2.9531 2.3834 1.5359 0.556
J_Cancer 0 0 0.9563 1.1081 1.038 0 1.6705 2.4636 1.9831 1.128
J_Dementia 0 1.6905 2.2441 2.1142 1.6198 0 2.1456 1.4409 0.2448 -0.173
J_Chd_Hf 1.0587 1.5335 1.8939 1.6331 1.3575 1.7884 2.5896 1.6087 1.1772 0.6634
J_Diab_Copd_Asthma 0 1.7557 2.0047 1.6978 1.4417 0 2.363 1.7367 1.3034 0.6125
J_Diab_Chd_Hf 0 0 2.0736 1.7209 1.41 0 0 1.9397 1.412 0.7075
J_Copd_Asthma_Chd_Hf 0 1.6316 2.4254 2.0786 1.5914 0 2.4526 1.7264 1.2406 0.7314
J_Copd_Asthma_Cancer 0 0 1.2425 1.6223 1.3101 0 3.696 2.6113 1.9732 1.1262
J_Multiple 0 2.2356 2.6384 2.1747 1.7851 1.619 2.5909 2.1024 1.3805 0.5233
Regression resultsModel: EL NEL
Age split: 0 01-19 20-49 50-84 85+ 0 01-19 20-49 50-84 85+
Intercept -3.0911 -2.9035 -3.6236 -2.3903 -1.3798 -0.1274 -1.6552 -2.5424 -3.6048 -2.0253
Female -0.3331 -0.0381 0.3052 -0.0636 -0.5792 -0.1872 -0.0455 0.1924 -0.0169 0.0235
Agecat 0 -0.0548 0.1073 0.0302 0 0 -0.2994 -0.0555 0.0369 0
Diedinyear 0 1.3189 -0.3864 -0.4784 -1.0779 0.7439 1.3486 1.0425 0.5855 0.1176
Gor_B -0.2163 0.0693 0.1332 0.27 0.2173 0.0455 -0.0722 0.0064 -0.0141 0.0467
Gor_D -0.4522 -0.0361 0.0073 0.1123 0.1765 -0.0907 -0.1913 -0.1002 0.0118 0.0554
Gor_E -0.3998 -0.1616 -0.0832 0.0834 0.1698 -0.0405 -0.3214 -0.1623 -0.0273 0.0532
Gor_F 0.2716 -0.1452 0.033 0.2478 0.1283 0.0776 -0.2473 -0.1158 -0.073 0.0333
Gor_G 0.1583 -0.1613 -0.0834 0.156 0.1589 -0.0823 -0.5078 -0.3375 -0.1081 -0.0372
Gor_H 0.1229 0.049 -0.091 0.2691 0.2312 -0.2392 -0.4926 -0.2614 0.0631 0.0956
Gor_J -0.2929 -0.1878 -0.234 0.0645 0.1602 -0.0726 -0.3531 -0.2542 -0.0247 0.0317
Gor_K -0.0279 0.0112 0.0496 0.2435 0.2663 -0.1416 -0.3755 -0.1928 -0.0693 0.0718
J_Diab 0 2.544 2.3993 2.0987 1.4491 0 3.4513 2.9732 2.4837 1.814
J_Copd_Asthma 2.3917 2.5127 2.1941 1.9535 1.3185 1.3183 3.0093 2.6959 2.7514 2.0378
J_Arthritis 3.1775 4.2375 2.9409 2.3424 1.5695 1.5861 2.6431 2.4063 2.428 1.9785
J_Epilepsy 3.6022 3.2657 2.0034 1.8165 1.2899 1.8695 3.3684 3.1692 3.0783 2.0691
J_Mh 0 0.9711 0.1642 0.1071 0 0 3.0474 2.5109 2.3812 0.9601
J_Stroke 2.5834 3.8182 1.993 1.1163 0.3526 1.2753 3.4446 3.4052 3.1883 2.239
J_Renal 2.1591 5.0979 5.2822 4.3031 2.4376 0.8138 3.6363 3.3981 3.104 2.1817
J_Cancer 0 3.788 3.9351 3.1234 1.8148 0 2.4094 2.4854 2.5009 1.8553
J_Dementia 0 2.4983 1.7571 0.7814 0 0 4.4186 3.6701 3.2308 2.3127
J_Chd_Hf 2.8109 3.1892 2.1599 1.8811 1.2379 1.5407 3.3538 3.4068 2.875 2.1599
J_Diab_Copd_Asthma 0 2.3739 2.3066 1.9488 1.0429 0 3.9546 3.2913 2.8791 2.1382
J_Diab_Chd_Hf 0 0 2.3935 1.9036 1.3684 0 0 3.4775 3.0018 2.218
J_Copd_Asthma_Chd_Hf 0 3.1661 2.2719 1.871 1.3322 0 3.0054 3.7611 3.2692 2.4
J_Copd_Asthma_Cancer 0 3.6543 3.8641 3.0159 1.827 0 0 2.8348 2.975 2.269
J_Multiple 2.733 4.0298 3.5188 2.614 1.2044 0.73 3.9302 3.8137 3.4138 2.5759
Keep in touch
For all the latest news and developments
from the Health Foundation:
Visit our website at www.health.org.uk
Subscribe to our monthly email newsletter at
www.health.org.uk/newsletter
Register for email alerts to be notified about our latest work at
www.health.org.uk/updates
Take part in conversation and debate about current health care
issues on our blog
Follow us on Twitter, Facebook or LinkedIn.
Keep in touch
For all the latest news and developments
from the Health Foundation:
30

More Related Content

What's hot

Understanding the drivers of hospital expenditure
Understanding the drivers of hospital expenditure Understanding the drivers of hospital expenditure
Understanding the drivers of hospital expenditure
Economic and Social Research Institute
 
'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard
'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard
'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard
Grant Goddard
 
Health sector 2016 budget performance
Health sector 2016 budget performanceHealth sector 2016 budget performance
Health sector 2016 budget performance
statisense
 
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...
DrWilliamBehan
 
The Saturday Economist, UK Service sector update October 2013
The Saturday Economist, UK Service sector update October 2013The Saturday Economist, UK Service sector update October 2013
The Saturday Economist, UK Service sector update October 2013
John Ashcroft
 
Economic Forum Webinar 8 July 2020
Economic Forum Webinar 8 July 2020 Economic Forum Webinar 8 July 2020
Economic Forum Webinar 8 July 2020
Office for National Statistics
 
Chamber presentation
Chamber presentationChamber presentation
Chamber presentation
Cyrus Patten, LICSW
 
Economic Forum 25 February 2020
Economic Forum 25 February 2020Economic Forum 25 February 2020
Economic Forum 25 February 2020
Office for National Statistics
 
Pressreleasecpi sint maarten_201306
Pressreleasecpi sint maarten_201306Pressreleasecpi sint maarten_201306
Pressreleasecpi sint maarten_201306PearlRadio Station
 
3Q2015 Economic Metrics (002)
3Q2015 Economic Metrics (002)3Q2015 Economic Metrics (002)
3Q2015 Economic Metrics (002)James Wacht
 
11.11.2015 macro risk outlook ankhbayar mandal- eng (1)
11.11.2015 macro risk outlook   ankhbayar mandal- eng (1)11.11.2015 macro risk outlook   ankhbayar mandal- eng (1)
11.11.2015 macro risk outlook ankhbayar mandal- eng (1)
The Business Council of Mongolia
 
Economic outlook september 2014
Economic outlook september 2014Economic outlook september 2014
Economic outlook september 2014
Paul Verschueren
 
Anita Charlesworth: Austerity and quality
Anita Charlesworth: Austerity and qualityAnita Charlesworth: Austerity and quality
Anita Charlesworth: Austerity and qualityQualityWatch
 

What's hot (14)

Understanding the drivers of hospital expenditure
Understanding the drivers of hospital expenditure Understanding the drivers of hospital expenditure
Understanding the drivers of hospital expenditure
 
'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard
'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard
'United Kingdom Commercial Radio: Q1 2008' by Grant Goddard
 
Health sector 2016 budget performance
Health sector 2016 budget performanceHealth sector 2016 budget performance
Health sector 2016 budget performance
 
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...
Vasco Da Gama 2015 Dublin The Effect of the Economic Crisis on the Irish Heal...
 
The Saturday Economist, UK Service sector update October 2013
The Saturday Economist, UK Service sector update October 2013The Saturday Economist, UK Service sector update October 2013
The Saturday Economist, UK Service sector update October 2013
 
Economic Forum Webinar 8 July 2020
Economic Forum Webinar 8 July 2020 Economic Forum Webinar 8 July 2020
Economic Forum Webinar 8 July 2020
 
Chamber presentation
Chamber presentationChamber presentation
Chamber presentation
 
Economic Forum 25 February 2020
Economic Forum 25 February 2020Economic Forum 25 February 2020
Economic Forum 25 February 2020
 
Pressreleasecpi sint maarten_201306
Pressreleasecpi sint maarten_201306Pressreleasecpi sint maarten_201306
Pressreleasecpi sint maarten_201306
 
3Q2015 Economic Metrics (002)
3Q2015 Economic Metrics (002)3Q2015 Economic Metrics (002)
3Q2015 Economic Metrics (002)
 
3Q2015 Economic Metrics
3Q2015 Economic Metrics3Q2015 Economic Metrics
3Q2015 Economic Metrics
 
11.11.2015 macro risk outlook ankhbayar mandal- eng (1)
11.11.2015 macro risk outlook   ankhbayar mandal- eng (1)11.11.2015 macro risk outlook   ankhbayar mandal- eng (1)
11.11.2015 macro risk outlook ankhbayar mandal- eng (1)
 
Economic outlook september 2014
Economic outlook september 2014Economic outlook september 2014
Economic outlook september 2014
 
Anita Charlesworth: Austerity and quality
Anita Charlesworth: Austerity and qualityAnita Charlesworth: Austerity and quality
Anita Charlesworth: Austerity and quality
 

Viewers also liked

National health service corp presentation to mo rhit may 27 2010
National health service corp presentation to mo rhit may 27 2010National health service corp presentation to mo rhit may 27 2010
National health service corp presentation to mo rhit may 27 2010learfield
 
Quality management principles
Quality management principlesQuality management principles
Quality management principlesMohit Singla
 
Consumer protection act in Medical Profession
Consumer protection act in Medical ProfessionConsumer protection act in Medical Profession
Consumer protection act in Medical Profession
Har Jindal
 
How is the new NHS structured?
How is the new NHS structured?How is the new NHS structured?
How is the new NHS structured?
The King's Fund
 
ppt on government budget
ppt on government budgetppt on government budget
ppt on government budget
Kushagra Arora
 
Classification of patient care
Classification of patient careClassification of patient care
Classification of patient carechrissie argana
 
Total Quality Management (TQM)
Total Quality Management (TQM)Total Quality Management (TQM)
Total Quality Management (TQM)Mudassar Salman
 

Viewers also liked (7)

National health service corp presentation to mo rhit may 27 2010
National health service corp presentation to mo rhit may 27 2010National health service corp presentation to mo rhit may 27 2010
National health service corp presentation to mo rhit may 27 2010
 
Quality management principles
Quality management principlesQuality management principles
Quality management principles
 
Consumer protection act in Medical Profession
Consumer protection act in Medical ProfessionConsumer protection act in Medical Profession
Consumer protection act in Medical Profession
 
How is the new NHS structured?
How is the new NHS structured?How is the new NHS structured?
How is the new NHS structured?
 
ppt on government budget
ppt on government budgetppt on government budget
ppt on government budget
 
Classification of patient care
Classification of patient careClassification of patient care
Classification of patient care
 
Total Quality Management (TQM)
Total Quality Management (TQM)Total Quality Management (TQM)
Total Quality Management (TQM)
 

Similar to The Outlook for NHS Funding

Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18
NevinInstitute
 
Hospital finances and productivity: in a critical condition?
Hospital finances and productivity: in a critical condition?Hospital finances and productivity: in a critical condition?
Hospital finances and productivity: in a critical condition?
The Health Foundation
 
Health system expenditure review: Slovenia
Health system expenditure review: SloveniaHealth system expenditure review: Slovenia
Health system expenditure review: Slovenia
OECD Governance
 
DELSA/GOV 3rd Health meeting - Ankit KUMAR
DELSA/GOV 3rd Health meeting - Ankit KUMARDELSA/GOV 3rd Health meeting - Ankit KUMAR
DELSA/GOV 3rd Health meeting - Ankit KUMAR
OECD Governance
 
DELSA/GOV Health - Session 1 - Ankit Kumar - oecd
DELSA/GOV Health - Session 1 - Ankit Kumar - oecdDELSA/GOV Health - Session 1 - Ankit Kumar - oecd
DELSA/GOV Health - Session 1 - Ankit Kumar - oecdOECD Governance
 
Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...
Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...
Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...
Economic Research Forum
 
Draft Financial recovery plan for NHS Eastern Cheshire CCG
Draft Financial recovery plan for NHS Eastern Cheshire CCGDraft Financial recovery plan for NHS Eastern Cheshire CCG
Draft Financial recovery plan for NHS Eastern Cheshire CCG
Matthew Cunningham
 
Projections of expenditure for public hospitals in Ireland, 2018 to 2035
Projections of expenditure for public hospitals in Ireland, 2018 to 2035 Projections of expenditure for public hospitals in Ireland, 2018 to 2035
Projections of expenditure for public hospitals in Ireland, 2018 to 2035
Economic and Social Research Institute
 
Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...
Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...
Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...achapkenya
 
Australia-oecd-economic-survey-main-findings
Australia-oecd-economic-survey-main-findingsAustralia-oecd-economic-survey-main-findings
Australia-oecd-economic-survey-main-findings
OECD, Economics Department
 
DELSA/GOV 3rd Health meeting - David MOLONEY
DELSA/GOV 3rd Health meeting - David MOLONEYDELSA/GOV 3rd Health meeting - David MOLONEY
DELSA/GOV 3rd Health meeting - David MOLONEY
OECD Governance
 
Financial recovery plan for NHS Eastern Cheshire CCG
Financial recovery plan for NHS Eastern Cheshire CCGFinancial recovery plan for NHS Eastern Cheshire CCG
Financial recovery plan for NHS Eastern Cheshire CCG
Matthew Cunningham
 
Budget report 2014
Budget report 2014Budget report 2014
Budget report 2014
Simon Peters
 
Income tax personal allowance for those aged under 65
Income tax personal allowance for those aged under 65Income tax personal allowance for those aged under 65
Income tax personal allowance for those aged under 65
Keyconsulting UK
 
The productivity challenge - John Appleby
The productivity challenge - John ApplebyThe productivity challenge - John Appleby
The productivity challenge - John Appleby
The King's Fund
 
Fiscal Policy (Austerity) in the UK Economy
Fiscal Policy (Austerity) in the UK EconomyFiscal Policy (Austerity) in the UK Economy
Fiscal Policy (Austerity) in the UK Economy
tutor2u
 
Bd govt expenditure in health sector
Bd govt expenditure in health sectorBd govt expenditure in health sector
Bd govt expenditure in health sector
sumaiyahamid
 
Dinámica del Gasto en Salud
Dinámica del Gasto en SaludDinámica del Gasto en Salud
Dinámica del Gasto en Salud
Carlos Javier Regazzoni
 
Economic Forum - 16 May 2022
Economic Forum - 16 May 2022Economic Forum - 16 May 2022
Economic Forum - 16 May 2022
Office for National Statistics
 
Healthcare Market Review 2015 - Colliers International.PDF
Healthcare Market Review 2015 - Colliers International.PDFHealthcare Market Review 2015 - Colliers International.PDF
Healthcare Market Review 2015 - Colliers International.PDFJames Shorthouse
 

Similar to The Outlook for NHS Funding (20)

Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18Slides NERI Seminar - PGK & TH - 12 Sept 18
Slides NERI Seminar - PGK & TH - 12 Sept 18
 
Hospital finances and productivity: in a critical condition?
Hospital finances and productivity: in a critical condition?Hospital finances and productivity: in a critical condition?
Hospital finances and productivity: in a critical condition?
 
Health system expenditure review: Slovenia
Health system expenditure review: SloveniaHealth system expenditure review: Slovenia
Health system expenditure review: Slovenia
 
DELSA/GOV 3rd Health meeting - Ankit KUMAR
DELSA/GOV 3rd Health meeting - Ankit KUMARDELSA/GOV 3rd Health meeting - Ankit KUMAR
DELSA/GOV 3rd Health meeting - Ankit KUMAR
 
DELSA/GOV Health - Session 1 - Ankit Kumar - oecd
DELSA/GOV Health - Session 1 - Ankit Kumar - oecdDELSA/GOV Health - Session 1 - Ankit Kumar - oecd
DELSA/GOV Health - Session 1 - Ankit Kumar - oecd
 
Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...
Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...
Determinants and Impact of Household's Out-Of–Pocket Healthcare Expenditure i...
 
Draft Financial recovery plan for NHS Eastern Cheshire CCG
Draft Financial recovery plan for NHS Eastern Cheshire CCGDraft Financial recovery plan for NHS Eastern Cheshire CCG
Draft Financial recovery plan for NHS Eastern Cheshire CCG
 
Projections of expenditure for public hospitals in Ireland, 2018 to 2035
Projections of expenditure for public hospitals in Ireland, 2018 to 2035 Projections of expenditure for public hospitals in Ireland, 2018 to 2035
Projections of expenditure for public hospitals in Ireland, 2018 to 2035
 
Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...
Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...
Kenya health sector reforms and roadmap towards uhc by Dr Isaaq Odongo, MOH K...
 
Australia-oecd-economic-survey-main-findings
Australia-oecd-economic-survey-main-findingsAustralia-oecd-economic-survey-main-findings
Australia-oecd-economic-survey-main-findings
 
DELSA/GOV 3rd Health meeting - David MOLONEY
DELSA/GOV 3rd Health meeting - David MOLONEYDELSA/GOV 3rd Health meeting - David MOLONEY
DELSA/GOV 3rd Health meeting - David MOLONEY
 
Financial recovery plan for NHS Eastern Cheshire CCG
Financial recovery plan for NHS Eastern Cheshire CCGFinancial recovery plan for NHS Eastern Cheshire CCG
Financial recovery plan for NHS Eastern Cheshire CCG
 
Budget report 2014
Budget report 2014Budget report 2014
Budget report 2014
 
Income tax personal allowance for those aged under 65
Income tax personal allowance for those aged under 65Income tax personal allowance for those aged under 65
Income tax personal allowance for those aged under 65
 
The productivity challenge - John Appleby
The productivity challenge - John ApplebyThe productivity challenge - John Appleby
The productivity challenge - John Appleby
 
Fiscal Policy (Austerity) in the UK Economy
Fiscal Policy (Austerity) in the UK EconomyFiscal Policy (Austerity) in the UK Economy
Fiscal Policy (Austerity) in the UK Economy
 
Bd govt expenditure in health sector
Bd govt expenditure in health sectorBd govt expenditure in health sector
Bd govt expenditure in health sector
 
Dinámica del Gasto en Salud
Dinámica del Gasto en SaludDinámica del Gasto en Salud
Dinámica del Gasto en Salud
 
Economic Forum - 16 May 2022
Economic Forum - 16 May 2022Economic Forum - 16 May 2022
Economic Forum - 16 May 2022
 
Healthcare Market Review 2015 - Colliers International.PDF
Healthcare Market Review 2015 - Colliers International.PDFHealthcare Market Review 2015 - Colliers International.PDF
Healthcare Market Review 2015 - Colliers International.PDF
 

More from cheweb1

The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...
cheweb1
 
Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...
cheweb1
 
Withinfamily che presentation_200609
Withinfamily che presentation_200609Withinfamily che presentation_200609
Withinfamily che presentation_200609
cheweb1
 
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
cheweb1
 
Valuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patientValuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patient
cheweb1
 
Health Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for SponsorsHealth Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for Sponsors
cheweb1
 
Modeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policiesModeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policies
cheweb1
 
Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2
cheweb1
 
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
cheweb1
 
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertaintiesCost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
cheweb1
 
Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...
cheweb1
 
The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...
cheweb1
 
Adjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trialsAdjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trials
cheweb1
 
Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)
cheweb1
 
Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)
cheweb1
 
The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...
cheweb1
 
Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...
cheweb1
 
Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...
cheweb1
 
Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...
cheweb1
 
Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...
cheweb1
 

More from cheweb1 (20)

The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...The value of Value of Information (VoI): When and how to use simpler or heuri...
The value of Value of Information (VoI): When and how to use simpler or heuri...
 
Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...Dynamic survival models for predicting the future in health technology assess...
Dynamic survival models for predicting the future in health technology assess...
 
Withinfamily che presentation_200609
Withinfamily che presentation_200609Withinfamily che presentation_200609
Withinfamily che presentation_200609
 
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
 
Valuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patientValuation in health economics: Reflections of a UK health economist… and patient
Valuation in health economics: Reflections of a UK health economist… and patient
 
Health Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for SponsorsHealth Research Authority Approval: Information for Sponsors
Health Research Authority Approval: Information for Sponsors
 
Modeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policiesModeling the cost effectiveness of two big league pay-for-performance policies
Modeling the cost effectiveness of two big league pay-for-performance policies
 
Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2Baker what to do when people disagree che york seminar jan 2019 v2
Baker what to do when people disagree che york seminar jan 2019 v2
 
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...The longest-lasting, most popular, and yet most thoroughly discredited idea i...
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
 
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertaintiesCost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
 
Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...Insights from actuarial science into HTA: Building joint models of random qua...
Insights from actuarial science into HTA: Building joint models of random qua...
 
The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...The implications of parameter independence in probabilistic sensitivity analy...
The implications of parameter independence in probabilistic sensitivity analy...
 
Adjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trialsAdjusting for treatment switching in randomised controlled trials
Adjusting for treatment switching in randomised controlled trials
 
Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits (part 2)
 
Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)Discounting future healthcare costs and benefits(Part 1)
Discounting future healthcare costs and benefits(Part 1)
 
The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...The reference ICER for the Australian health system: estimation and barriers ...
The reference ICER for the Australian health system: estimation and barriers ...
 
Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...Valuing paediatric preference-based measures: using a discrete choice experim...
Valuing paediatric preference-based measures: using a discrete choice experim...
 
Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...Does transfer to intensive care units reduce mortality for deteriorating ward...
Does transfer to intensive care units reduce mortality for deteriorating ward...
 
Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...Economic evaluation of changes to the organisation and delivery of health ser...
Economic evaluation of changes to the organisation and delivery of health ser...
 
Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...Quantifying the added societal value of public health interventions in reduci...
Quantifying the added societal value of public health interventions in reduci...
 

Recently uploaded

24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 

Recently uploaded (20)

24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 

The Outlook for NHS Funding

  • 1. The NHS Funding Challenge ‘productivity isn’t everything, but in the long run it is almost everything’ - Paul Krugman Anita Charlesworth Chief Economist 5th February 2015
  • 2. Public spending on health in the UK, in real terms and as a percentage of GDP (2014/15 prices) 2
  • 3. Average yearly change in UK health spending over different parliaments (2014/15 prices) 3
  • 4. The annual change in English NHS spending since 2009/10 4
  • 5. Public and private health care spending in the UK (£bn) – 1997-2012 (2014/15 prices) 5
  • 6. Total health spending as a percentage of GDP for the EU-15 countries, 2000 and 2012 6
  • 7. Average annual percentage change in health spending per head in real terms, 2008-2012 7
  • 8. Meeting the Challenge – the NHS approach 8 Reducing input costs National public sector pay policy Reducing administrative costs Reducing prices of pharmaceuticals Improving technical efficiency Real terms reduction in the unit prices paid for hospital care More competitive tender and choice based competition for NHS funded care Improving allocative efficiency Shifting care from hospital to community settings Better integration of care Demand management
  • 9. Where is the NHS now? 9 Overall NHS in balance last year (just £247m under-spend for DH as a whole in 2013/14). Quality broadly being maintained but cracks beginning to appear. But significant pressure points. Specialised services budget over-spending. Access targets getting more difficult to sustain. 66 NHS providers in deficit in 2013/14 – almost 141 at Q2 2014/15. Most have a small deficit but up to 20 with large, persistent deficits. 40% of acute providers in deficit in 2013/14, 80% at Q2 2014/15. Surpluses falling, EBITDA and CIPs lower and a reliance on one-off savings building cumulative underlying deficits. 2014-15 very difficult for the service to recover and not overspend.
  • 10. -2% -1% 0% 1% 2% 3% 4% 5% 2005/06 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12 Annual average growth Productivity Growth Year on Year Annual change in English NHS productivity 10 Source: Centre for Health Economics, Research Paper 94
  • 11. Annual change in English NHS funding, 2010/11 to 2015/16, following the 2014 Autumn Statement
  • 12. NHS administration costs from 2009/10 to 2015/16, real terms 12
  • 13. Percentage change from previous year in funding for a range of services 13
  • 14. Purchase of health care from non-NHS providers from 2006/07 to 2013/14 (2013/14 prices) 14
  • 15. Annual change in the number of nurses from 2011/12 to 2013/14 15
  • 16. Average NHS staff earnings from 2009/10 to 2013/14 16
  • 17. Net reported year-to-date surplus/deficit by sector, 2014/15 Q2 17
  • 18. Quality, Innovation and Productivity (QIPP) savings, 2011/12 to 2014/15 18
  • 19. Public spending on health in the UK, as a percentage of total public spending 19
  • 20. NHS England estimates of funding pressures facing the NHS in England by the end of the decade 20
  • 21. Health care outputs, inputs and productivity estimates for the UK, 1995-2010 (index numbers 1995=100) 21
  • 22. Projected funding gap for English NHS in 2030/31 under three assumptions for productivity 22 Source: The Health Foundation (2015)
  • 23. Funding pressures on English NHS in 2030/31 (2014/15 prices) 23
  • 24. OECD projections for average public spending on health for EU15 countries, as a percentage of GDP between 2006 and 2010, with projected spend in 2060 under both cost-containment and cost-pressure assumptions 24
  • 25. Conclusions 25 The NHS has been protected from the full impact of the government’s austerity drive to tackle the fiscal deficit. Despite this, the service is showing growing signs of financial distress and in December 2014, the Government found itself having to inject significant additional resources into the service for both 2014/15 and 2015/16. After the election, all political parties are committed to reducing the fiscal deficit, which will involve cuts to public spending. Health care now accounts for almost £1 in every £5 of government spending – just sustaining, let alone improving, the quality of care while delivering fiscal balance will be one of the major challenges facing any incoming government. NHS England has set out an ambitious programme of reform for the NHS in the recent Five year forward view. This is designed to improve the system’s productivity and modernise care to ensure that it meets the needs of an ageing population with growing rates of chronic disease. There is no doubt that change on this scale is required. The key question is can it be delivered quickly enough to unlock the required productivity savings. Under NHS England’s most demanding productivity assumption, they recognise that the NHS will still need an addition £8bn extra over and above inflation by 2020/21.
  • 26. Conclusions 26 An incoming government needs to:  Provide meaningful support for rapid progress on the new models of care set out in the Five year forward view. A key part of this support will be to establish and resource a ‘transformation’ fund to provide the financial assistance necessary to underpin change.  Commit to the additional annual funding for the NHS specified by NHS England, which rises to £8 billion of additional funding over and above inflation in 2020/21, while recognising that this is a low estimate and if pay pressures turn out to be higher than anticipated, the NHS will need further resources to maintain quality and access. The funding challenge facing the NHS doesn’t disappear beyond the current parliament even if the NHS succeeds in implementing the vision set out in the Five year forward view.  Even with unprecedented productivity improvements of over 2 per cent a year the funding pressures facing the NHS would rise to £48 billion more than inflation by 2030/31.  Our central estimates using the recent trend of 1.5% productivity improvements see funding pressures increasing to £65 billion more than inflation by 2030/31. If successive governments are to meet these pressures NHS funding needs to grow slightly faster than GDP. Over recent decades other public services have reduced as a share of GDP, creating headroom for the health service without the need to increase taxes. It is difficult to see how this can continue indefinitely and there needs to be societal agreement about how to sustain the health service in the longer term.
  • 27. The four steps used to project funding pressures
  • 28. Regression results 28 Model: AE OP Age split: 0 01-19 20-49 50-84 85+ 0 01-19 20-49 50-84 85+ Intercept -0.6403 -0.6555 -0.2141 -1.764 -1.2116 -0.3276 -0.459 -0.5608 -1.0967 0.9262 Female -0.1843 -0.1687 -0.1061 0 0 -0.1762 0.0224 0.7969 0.0464 -0.2718 Agecat 0 -0.0607 -0.112 0 0 0 0.022 0.0104 0.0991 0 Diedinyear 0 0.2948 0.7057 0.2715 -0.1321 0.1983 0.7421 0.1455 -0.483 -1.0498 Gor_B 0.2138 -0.0508 0.0542 0.0961 0.1369 0.1089 -0.1299 0.0356 0.1153 0.1269 Gor_D -0.0313 -0.1905 -0.1857 -0.0974 -0.0063 -0.0888 -0.1455 -0.1782 0.0039 0.0653 Gor_E -0.1832 -0.295 -0.2692 -0.1582 -0.1264 0.0306 -0.2367 -0.183 -0.0559 -0.047 Gor_F 0.0546 -0.1564 -0.0331 0.0471 0.0689 0.2798 -0.0566 0.088 0.1964 0.1982 Gor_G -0.2545 -0.4819 -0.4141 -0.253 -0.1051 0.1938 -0.2372 -0.1661 -0.0715 -0.0564 Gor_H 0.3691 0.0308 0.0054 0.3736 0.3134 0.1484 -0.0777 0.0759 0.3236 0.4349 Gor_J -0.3327 -0.459 -0.3825 -0.1739 -0.0619 0.2504 -0.2298 -0.2413 -0.1213 -0.0662 Gor_K -0.3657 -0.3064 -0.2747 -0.151 -0.1981 0.057 -0.0668 -0.1598 -0.0016 0.0583 J_Diab 2.0715 1.3932 1.6104 1.3196 1.0511 0 2.2116 1.8219 1.2987 0.7136 J_Copd_Asthma 1.0337 1.5459 1.5297 1.6106 1.2884 1.19 1.5803 1.436 1.1796 0.6371 J_Arthritis 1.4887 0.9166 1.2038 1.2692 1.2351 0 2.7632 1.9332 1.4955 0.6891 J_Epilepsy 1.7454 1.719 2.0015 2.0342 1.465 2.0379 2.3319 1.511 1.1205 0.6032 J_Mh 0 1.9026 1.9337 1.9558 0.7855 0 0.7935 0.3779 0.2489 0 J_Stroke 0.8288 1.3728 1.8504 1.8854 1.4531 2.1757 2.5433 1.5959 0.8992 0.3001 J_Renal 0 1.3425 1.5858 1.5909 1.3334 1.8159 2.9531 2.3834 1.5359 0.556 J_Cancer 0 0 0.9563 1.1081 1.038 0 1.6705 2.4636 1.9831 1.128 J_Dementia 0 1.6905 2.2441 2.1142 1.6198 0 2.1456 1.4409 0.2448 -0.173 J_Chd_Hf 1.0587 1.5335 1.8939 1.6331 1.3575 1.7884 2.5896 1.6087 1.1772 0.6634 J_Diab_Copd_Asthma 0 1.7557 2.0047 1.6978 1.4417 0 2.363 1.7367 1.3034 0.6125 J_Diab_Chd_Hf 0 0 2.0736 1.7209 1.41 0 0 1.9397 1.412 0.7075 J_Copd_Asthma_Chd_Hf 0 1.6316 2.4254 2.0786 1.5914 0 2.4526 1.7264 1.2406 0.7314 J_Copd_Asthma_Cancer 0 0 1.2425 1.6223 1.3101 0 3.696 2.6113 1.9732 1.1262 J_Multiple 0 2.2356 2.6384 2.1747 1.7851 1.619 2.5909 2.1024 1.3805 0.5233
  • 29. Regression resultsModel: EL NEL Age split: 0 01-19 20-49 50-84 85+ 0 01-19 20-49 50-84 85+ Intercept -3.0911 -2.9035 -3.6236 -2.3903 -1.3798 -0.1274 -1.6552 -2.5424 -3.6048 -2.0253 Female -0.3331 -0.0381 0.3052 -0.0636 -0.5792 -0.1872 -0.0455 0.1924 -0.0169 0.0235 Agecat 0 -0.0548 0.1073 0.0302 0 0 -0.2994 -0.0555 0.0369 0 Diedinyear 0 1.3189 -0.3864 -0.4784 -1.0779 0.7439 1.3486 1.0425 0.5855 0.1176 Gor_B -0.2163 0.0693 0.1332 0.27 0.2173 0.0455 -0.0722 0.0064 -0.0141 0.0467 Gor_D -0.4522 -0.0361 0.0073 0.1123 0.1765 -0.0907 -0.1913 -0.1002 0.0118 0.0554 Gor_E -0.3998 -0.1616 -0.0832 0.0834 0.1698 -0.0405 -0.3214 -0.1623 -0.0273 0.0532 Gor_F 0.2716 -0.1452 0.033 0.2478 0.1283 0.0776 -0.2473 -0.1158 -0.073 0.0333 Gor_G 0.1583 -0.1613 -0.0834 0.156 0.1589 -0.0823 -0.5078 -0.3375 -0.1081 -0.0372 Gor_H 0.1229 0.049 -0.091 0.2691 0.2312 -0.2392 -0.4926 -0.2614 0.0631 0.0956 Gor_J -0.2929 -0.1878 -0.234 0.0645 0.1602 -0.0726 -0.3531 -0.2542 -0.0247 0.0317 Gor_K -0.0279 0.0112 0.0496 0.2435 0.2663 -0.1416 -0.3755 -0.1928 -0.0693 0.0718 J_Diab 0 2.544 2.3993 2.0987 1.4491 0 3.4513 2.9732 2.4837 1.814 J_Copd_Asthma 2.3917 2.5127 2.1941 1.9535 1.3185 1.3183 3.0093 2.6959 2.7514 2.0378 J_Arthritis 3.1775 4.2375 2.9409 2.3424 1.5695 1.5861 2.6431 2.4063 2.428 1.9785 J_Epilepsy 3.6022 3.2657 2.0034 1.8165 1.2899 1.8695 3.3684 3.1692 3.0783 2.0691 J_Mh 0 0.9711 0.1642 0.1071 0 0 3.0474 2.5109 2.3812 0.9601 J_Stroke 2.5834 3.8182 1.993 1.1163 0.3526 1.2753 3.4446 3.4052 3.1883 2.239 J_Renal 2.1591 5.0979 5.2822 4.3031 2.4376 0.8138 3.6363 3.3981 3.104 2.1817 J_Cancer 0 3.788 3.9351 3.1234 1.8148 0 2.4094 2.4854 2.5009 1.8553 J_Dementia 0 2.4983 1.7571 0.7814 0 0 4.4186 3.6701 3.2308 2.3127 J_Chd_Hf 2.8109 3.1892 2.1599 1.8811 1.2379 1.5407 3.3538 3.4068 2.875 2.1599 J_Diab_Copd_Asthma 0 2.3739 2.3066 1.9488 1.0429 0 3.9546 3.2913 2.8791 2.1382 J_Diab_Chd_Hf 0 0 2.3935 1.9036 1.3684 0 0 3.4775 3.0018 2.218 J_Copd_Asthma_Chd_Hf 0 3.1661 2.2719 1.871 1.3322 0 3.0054 3.7611 3.2692 2.4 J_Copd_Asthma_Cancer 0 3.6543 3.8641 3.0159 1.827 0 0 2.8348 2.975 2.269 J_Multiple 2.733 4.0298 3.5188 2.614 1.2044 0.73 3.9302 3.8137 3.4138 2.5759
  • 30. Keep in touch For all the latest news and developments from the Health Foundation: Visit our website at www.health.org.uk Subscribe to our monthly email newsletter at www.health.org.uk/newsletter Register for email alerts to be notified about our latest work at www.health.org.uk/updates Take part in conversation and debate about current health care issues on our blog Follow us on Twitter, Facebook or LinkedIn. Keep in touch For all the latest news and developments from the Health Foundation: 30